Home » Newsletters » BioWorld Science

BioWorld Science

March 2, 2011

View Archived Issues

Germline SNPs inked to outcome of docetaxel-treated metastatic castration-resistant prostate cancer

Soluble CD276 antigen in expressed prostatic secretions is a biomarker of chronic prostatitis

RITA has synergistic activity with chemotherapeutic agents in MM cells in vitro

Regeneron reports new phase III data on Arcalyst for prevention of gout flares

New modified sesamol derivative INV-403 suppresses atherosclerosis in vivo

Nile Therapeutics and Medtronic collaborate on development of cenderitide

New phase II trial evaluates Prostvac with docetaxel in prostate cancer

New inhibitors of cGMP-specific 3',5'-cyclic phosphodiesterase claimed

Pfizer completes acquisition of King Pharmaceuticals

New inhibitors patented of enoyl-[acyl-carrier-protein] reductase [NADH]

Kyorin and Almirall sign license agreement for aclidinium bromide in Japan

Daiichi Sankyo to acquire Plexxikon

Medivir's Xerese launched in the U.S. as prescription cold sore treatment

FDA grants Epeius' anticancer gene therapy Rexin-G phase III status

Mochida Pharma requests Japanese approval for Beselna in solar keratoses

Novartis seeks approval in Japan for Certican to prevent renal transplant rejection

Gemzar approved in Japan for ovarian cancer after chemotherapy

Novavax receives contract to develop flu vaccines for U.S. government

Seattle Genetics and Millennium begin phase I trial of brentuximab vedotin

Oxygen Biotherapeutics receives grant from U.S. army to study Oxycyte in traumatic brain injury

NPS Pharma advances pivotal REPLACE trial of NPSP-558 in hypoparathyroidism

European approval for Xiapex for Dupuytren's contracture

HIV reverse transcriptase inhibitors patented by AiCuris

Novel inhibitors of 11-beta-HSD1 presented

Selexagen discloses new sonic hedgehog protein inhibitors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...